WebSep 5, 2024 · Contacts. OSE Immunotherapeutics Sylvie Détry [email protected] +33 153 198 757 Investor Relations Thomas Guillot thomas.guillot@ose … WebApr 5, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Reference Document filed with the AMF on 8 June 2016 under the number R.16-052, the ...
OSE Immunotherapeutics Receives New European Patent Notice …
WebJan 3, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … WebSep 30, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2024, including the... essay on paryatan sthal in hindi
OSE Immunotherapeutics and Veloxis Pharmaceuticals Enter …
WebSep 22, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … WebMar 15, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF … WebFeb 15, 2024 · This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2024, including the annual financial report for the fiscal year 2024, available on the OSE Immunotherapeutics’ website. finsbury park station to kings cross